TDOC
Teladoc Health·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Beats Expectation
Price Hits 52-week Low
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TDOC
Teladoc Health, Inc.
The global leader in whole-person virtual care
Healthcare Technology
06/13/2002
07/01/2015
New York Stock Exchange
5,500
12-31
Common stock
155 E 44th Street, Suite 1700, New York, New York 10017
--
Teladoc Health, Inc., was incorporated in Texas on June 13, 2002 and then changed its registered address to Delaware on October 16, 2008. The company is the world's largest and most trusted leader in integrated virtual healthcare services. The company is forging a new healthcare experience with better convenience, results and value. The company provides virtual access to a portfolio of services and solutions for high-quality care and expertise, covering more than 450 medical subspecialties, from non-urgent, incidental needs such as influenza and upper respiratory tract infections, to chronic, complex medical conditions such as cancer and congestive heart failure. Through a highly flexible technology platform that combines the latest data and analysis with an award-winning user experience, the company completed approximately 4.1 million telemedicine visits for patients worldwide in 2019.
Earnings Call
Company Financials
EPS
TDOC has released its 2025 Q3 earnings. EPS was reported at -0.28, versus the expected -0.31, beating expectations. The chart below visualizes how TDOC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TDOC has released its 2025 Q3 earnings report, with revenue of 626.44M, reflecting a YoY change of -2.20%, and net profit of -49.51M, showing a YoY change of -48.78%. The Sankey diagram below clearly presents TDOC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available

